The genomic landscape of small intestine neuroendocrine tumors von Banck, Michaela S, Kanwar, Rahul, Kulkarni, Amit A, Boora, Ganesh K, Metge, Franziska, Kipp, Benjamin R, Zhang, Lizhi, Thorland, Erik C, Minn, Kay T, Tentu, Ramesh, Eckloff, Bruce W, Wieben, Eric D, Wu, Yanhong, Cunningham, Julie M, Nagorney, David M, Gilbert, Judith A, Ames, Matthew M, Beutler, Andreas S

Volltext

Pharmacogenetics of Tamoxifen Biotransformation Is Associated With Clinical Outcomes of Efficacy and Hot Flashes von GOETZ, Matthew P, RAE, James M, DESTA, Zeruesenay, PEREZ, Edith A, INGLE, James N, SUMAN, Vera J, SAFGREN, Stephanie L, AMES, Matthew M, VISSCHER, Daniel W, REYNOLDS, Carol, COUCH, Fergus J, LINGLE, Wilma L, FLOCKHART, David A

Volltext

Phase II Trial of Vorinostat in Recurrent Glioblastoma Multiforme: A North Central Cancer Treatment Group Study von GALANIS, Evanthia, JAECKLE, Kurt A, RICHON, Victoria M, SCHEITHAUER, Bernd, GIANNINI, Caterina, FLYNN, Patrick J, MOORE, Dennis F, ZWIEBEL, James, BUCKNER, Jan C, MAURER, Matthew J, REID, Joel M, AMES, Matthew M, HARDWICK, James S, REILLY, John F, LOBODA, Andrey, NEBOZHYN, Michael, FANTIN, Valeria R

Volltext

CYP2D6 Metabolism and Patient Outcome in the Austrian Breast and Colorectal Cancer Study Group Trial (ABCSG) 8 von GOETZ, Matthew P, SUMAN, Vera J, DIETZE, Otto, LANG, Alois, OFFER, Felix, REYNOLDS, Carol A, WEINSHILBOUM, Richard M, AMES, Matthew M, INGLE, James N, HOSKIN, Tanya L, GNANT, Michael, FILIPITS, Martin, SAFGREN, Stephanie L, KUFFEL, Mary, JAKESZ, Raimund, RUDAS, Margaretha, GREIL, Richard

Volltext

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen von GOETZ, Matthew P, KNOX, Stacey K, WEINSHILBOUM, Richard M, FRITCHER, Emily G. Barr, NIBBE, Andrea M, DESTA, Zeruesenay, NGUYEN, Anne, FLOCKHART, David A, PEREZ, Edith A, INGLE, James N, SUMAN, Vera J, RAE, James M, SAFGREN, Stephanie L, AMES, Matthew M, VISSCHER, Daniel W, REYNOLDS, Carol, CONCH, Fergus J, LINGLE, Wilma L

Volltext

Targeted Delivery of Gemcitabine to Pancreatic Adenocarcinoma Using Cetuximab as a Targeting Agent von RANJAN PATRA, Chitta, BHATTACHARYA, Resham, YASZEMSKI, Michael J, REID, Joel M, AMES, Matthew M, MUKHERJEE, Priyabrata, MUKHOPADHYAY, Debabrata, ENFENG WANG, KATARYA, Aaron, LAU, Julie S, DUTTA, Shamit, MUDERS, Michael, SHANFENG WANG, BUHROW, Sarah A, SAFGREN, Stephanie L

Volltext

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report von FOULADI, Maryam, PARK, Julie R, ZWIEBEL, James, BLANEY, Susan M, ADAMSON, Peter C, STEWART, Clinton F, GILBERTSON, Richard J, SCHAIQUEVICH, Paula, JUNFENG SUN, REID, Joel M, AMES, Matthew M, SPEIGHTS, Roseanne, INGLE, Ashish M

Volltext

Coprescription of Tamoxifen and Medications That Inhibit CYP2D6 von SIDERAS, Kostandinos, INGLE, James N, AMES, Matthew M, LOPRINZI, Charles L, MRAZEK, David P, BLACK, John L, WEINSHILBOUM, Richard M, HAWSE, John R, SPELSBERG, Thomas C, GOETZ, Matthew P

Volltext

Antitumor activity of Z-endoxifen in aromatase inhibitor-sensitive and aromatase inhibitor-resistant estrogen receptor-positive breast cancer von Jayaraman, Swaathi, Hou, Xiaonan, Kuffel, Mary J, Suman, Vera J, Hoskin, Tanya L, Reinicke, Kathryn E, Monroe, David G, Kalari, Krishna R, Tang, Xiaojia, Zeldenrust, Megan A, Cheng, Jingfei, Bruinsma, Elizabeth S, Buhrow, Sarah A, McGovern, Renee M, Safgren, Stephanie L, Walden, Chad A, Carter, Jodi M, Reid, Joel M, Ingle, James N, Ames, Matthew M, Hawse, John R, Goetz, Matthew P

Volltext

Phase I Trial of Oral Fenretinide in Children With High-Risk Solid Tumors: A Report From the Children's Oncology Group (CCG 09709) von VILLABLANCA, Judith G, KRAILO, Mark D, AMES, Matthew M, REID, Joel M, REAMAN, Gregory H, REYNOLDS, Patrick C

Volltext

Selective estrogen receptor modulators and pharmacogenomic variation in ZNF423 regulation of BRCA1 expression: individualized breast cancer prevention von Ingle, James N, Liu, Mohan, Wickerham, D Lawrence, Schaid, Daniel J, Wang, Liewei, Mushiroda, Taisei, Kubo, Michiaki, Costantino, Joseph P, Vogel, Victor G, Paik, Soonmyung, Goetz, Matthew P, Ames, Matthew M, Jenkins, Gregory D, Batzler, Anthony, Carlson, Erin E, Flockhart, David A, Wolmark, Norman, Nakamura, Yusuke, Weinshilboum, Richard M

Volltext

Endoxifen downregulates AKT phosphorylation through protein kinase C beta 1 inhibition in ERα+ breast cancer von Jayaraman, Swaathi, Wu, Xinyan, Kalari, Krishna R., Tang, Xiaojia, Kuffel, Mary J., Bruinsma, Elizabeth S., Jalali, Shahrzad, Peterson, Kevin L., Correia, Cristina, Kudgus, Rachel A., Kaufmann, Scott H., Renuse, Santosh, Ingle, James N., Reid, Joel M., Ames, Matthew M., Fields, Alan P., Schellenberg, Matthew J., Hawse, John R., Pandey, Akhilesh, Goetz, Matthew P.

Volltext

Gemcitabine Pharmacogenomics: Cytidine Deaminase and Deoxycytidylate Deaminase Gene Resequencing and Functional Genomics von GILBERT, Judith A, SALAVAGGIONE, Oreste E, YUAN JI, PELLEYMOUNTER, Linda L, ECKLOFF, Bruce W, WIEBEN, Eric D, AMES, Matthew M, WEINSHILBOUM, Richard M

Volltext

Molecular markers for novel therapies in neuroendocrine (carcinoid) tumors von Gilbert, Judith A, Adhikari, Laura J, Lloyd, Ricardo V, Rubin, Joseph, Haluska, Paul, Carboni, Joan M, Gottardis, Marco M, Ames, Matthew M

Volltext

A Phase I Trial of Twice-Weekly 17-Allylamino-Demethoxy-Geldanamycin in Patients with Advanced Cancer von NOWAKOWSKI, Grzegorz S, MCCOLLUM, Andrea K, AMES, Matthew M, MANDREKAR, Sumithra J, REID, Joel M, ADJEI, Alex A, TOFT, David O, SAFGREN, Stephanie L, ERLICHMAN, Charles

Volltext

Toxicology and pharmacokinetics of 1-methyl- d-tryptophan: Absence of toxicity due to saturating absorption von Jia, Lee, Schweikart, Karen, Tomaszewski, Joseph, Page, John G., Noker, Patricia E., Buhrow, Sarah A., Reid, Joel M., Ames, Matthew M., Munn, David H.

Volltext

Phase I and pharmacological study of cytarabine and tanespimycin in relapsed and refractory acute leukemia von KAUFMANN, Scott H, KARP, Judith E, MAURER, Matthew J, DOUGLAS SMITH, B, GREER, Jacqueline, YUHONG CHEN, REID, Joel M, PERCY IVY, S, AMES, Matthew M, ADJEI, Alex A, ERLICHMAN, Charles, KARNITZ, Larry M, LITZOW, Mark R, MESA, Ruben A, HOGAN, William, STEENSMA, David P, FLATTEN, Karen S, LOEGERING, David A, SCHNEIDER, Paula A, PETERSON, Kevin L

Volltext

Association Between CYP2D6 Polymorphisms and Outcomes Among Women With Early Stage Breast Cancer Treated With Tamoxifen von Schroth, Werner, Goetz, Matthew P, Hamann, Ute, Fasching, Peter A, Schmidt, Marcus, Winter, Stefan, Fritz, Peter, Simon, Wolfgang, Suman, Vera J, Ames, Matthew M, Safgren, Stephanie L, Kuffel, Mary J, Ulmer, Hans Ulrich, Boländer, Julia, Strick, Reiner, Beckmann, Matthias W, Koelbl, Heinz, Weinshilboum, Richard M, Ingle, James N, Eichelbaum, Michel, Schwab, Matthias, Brauch, Hiltrud

Volltext

Gemcitabine and irinotecan as first-line therapy for carcinoma of unknown primary: results of a multicenter phase II trial von Holtan, Shernan G, Steen, Preston D, Foster, Nathan R, Erlichman, Charles, Medeiros, Fabiola, Ames, Matthew M, Safgren, Stephanie L, Graham, David L, Behrens, Robert J, Goetz, Matthew P

Volltext

Molecular analysis of metaplastic breast carcinoma: high EGFR copy number via aneusomy von Gilbert, Judith A, Goetz, Matthew P, Reynolds, Carol A, Ingle, James N, Giordano, Karin F, Suman, Vera J, Blair, Hilary E, Jenkins, Robert B, Lingle, Wilma L, Reinholz, Monica M, Adjei, Alex A, Ames, Matthew M

Volltext